Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.
第一作者:
Anouk,Emadali
第一单位:
CEA, iRTSV, Biologie à Grande Echelle, Grenoble, France.
作者:
医学主题词
动物(Animals);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗原, CD20(Antigens, CD20);抗肿瘤药(Antineoplastic Agents);吖庚因类(Azepines);细胞分化(Cell Differentiation);细胞系, 肿瘤(Cell Line, Tumor);细胞核(Cell Nucleus);细胞增殖(Cell Proliferation);后成说, 遗传(Epigenesis, Genetic);基因表达谱(Gene Expression Profiling);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因调控网络(Gene Regulatory Networks);基因沉默(Gene Silencing);人类(Humans);淋巴瘤(Lymphoma);淋巴瘤, B细胞(Lymphoma, B-Cell);小鼠(Mice);小鼠, SCID(Mice, SCID);肿瘤移植(Neoplasm Transplantation);蛋白质结构, 三级(Protein Structure, Tertiary);蛋白质组学(Proteomics);三唑类(Triazoles)
DOI
10.1002/emmm.201202034
PMID
23828858
发布时间
2021-10-21
- 浏览48
EMBO molecular medicine
1180-95页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



